Filing Details

Accession Number:
0001209191-22-008877
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-11 16:28:53
Reporting Period:
2022-02-10
Accepted Time:
2022-02-11 16:28:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
57725 Lannett Co Inc LCI Pharmaceutical Preparations (2834) 230787699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727305 C Timothy Crew 9000 State Road
Philadelphia PA 19136
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-10 50,000 $0.93 634,270 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Crew on December 2, 2021.
  2. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging between $0.87 to $1.00. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.